As policymakers renew interest in referencing foreign drug prices, like Most Favored Nation proposals, how widely could this shift the U.S. to reliance on QALYs in its health care decision-making?
|
In this week's edition...
-- Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below. — National Minority Quality Forum Issue Brief Details MFN Consequences. Click here to read the issue brief. — The Health Insurance Maze: How Cancer Patients Get Lost in the Red Tape of Utilization Management. See details below. — Clinicians Share Concerns About State PDAB Activities, According to a New Report from CancerCare. See details below. — Report: Foreign Countries Rely on Flawed and Outdated HTA or Value Assessment Methods. Click here to read the report. — Update on the Texas v. Kennedy Lawsuit. See details below. — Follow the Medicaid Debate. See details below. — CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below. — Learn More About Alternative Measures for Value Assessment. Click here to learn more. — Emerging Threats in States for Use of Discriminatory Metrics. See details below. — What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below. — ICER's QALY-Based Study Topics. See details below. — Upcoming Events and Webinars. See details below. — AHRQ Effective Program Updates. See details below. In this week's edition...
-- Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below. — National Minority Quality Forum Issue Brief Details MFN Consequences. Click here to read the issue brief. — Patient Groups Call Attention to Payer’s Discriminatory Policy. Click here to read the letter. — Report: Foreign Countries Rely on Flawed and Outdated HTA or Value Assessment Methods. Click here to read the report. — Update on the Texas v. Kennedy Lawsuit. See details below. — Follow the Medicaid Debate. See details below. — CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below. — Learn More About Alternative Measures for Value Assessment. Click here to learn more. — Emerging Threats in States for Use of Discriminatory Metrics. See details below. — What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below. — ICER's QALY-Based Study Topics. See details below. — Upcoming Events and Webinars. See details below. — AHRQ Effective Program Updates. See details below. In this week's edition...
— Another Threat to Medicaid & Medicare: Tell Policymakers to Avoid Modeling Countries that Ration Care, Devalue Disability. See details below. — National Minority Quality Forum Issue Brief Details MFN Consequences. Click here to read the issue brief. — PCORI Offers Scholarships for Patients, Caregivers, and PCORI Ambassadors. See details below. — Patient Groups Call Attention to Payer’s Discriminatory Policy. Click here to read the letter. — Report: Foreign Countries Rely on Flawed and Outdated HTA or Value Assessment Methods. Click here to read the report. — Update on the Texas v. Kennedy Lawsuit. See details below. — Follow the Medicaid Debate. See details below. — CMS References ICER and NICE in Explanations for Medicare Drug Price Negotiation Program. See details below. — Learn More About Alternative Measures for Value Assessment. Click here to learn more. — Emerging Threats in States for Use of Discriminatory Metrics. See details below. — What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below. — ICER's QALY-Based Study Topics. See details below. — Upcoming Events and Webinars. See details below. |
Topics
All
Archives
June 2025
|
